MedTrace Logo

IBD Registry in a Sub-Saharan African Population

NCT04178408 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2024-07-11

No results posted yet for this study

Summary

The investigators intend to establish a prospective registry of patients diagnosed with inflammatory bowel disease at Parirenyatwa hospital in Harare, Zimbabwe. The study will periodically collect data on disease phenotype, disease course, and clinical management, and will biobank stool specimens and germline DNA. One relative, and an individual from the same neighbourhood will be also be recruited for a nested case-control study into risk factors of inflammatory bowel disease in this population.

Conditions

Interventions

OTHER

No intervention

No intervention

Sponsors & Collaborators

  • Swiss IBDnet

    collaborator UNKNOWN

  • University of Bern

    collaborator OTHER

  • University of Zimbabwe

    lead OTHER

Principal Investigators

  • Leolin Katsidzira, MD · University of Zimbabwe

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-01-02
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • Zimbabwe

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04178408 on ClinicalTrials.gov